Does Severity of Donor Acute Kidney Injury Influence Outcomes Following Kidney Transplantation?

Clin Transplant. 2024 Aug;38(8):e15425. doi: 10.1111/ctr.15425.

Abstract

Introduction: The study purpose was to review retrospectively our single-center experience transplanting kidneys from deceased donors (DD) with acute kidney injury (AKI) according to terminal serum creatinine (tSCr) level.

Methods: AKI kidneys were defined by a doubling of the DD's admission SCr and a tSCr ≥ 2.0 mg/dL.

Results: From 1/07 to 11/21, we transplanted 236 AKI DD kidneys, including 100 with a tSCr ≥ 3.0 mg/dL (high SCr AKI group, mean tSCr 4.2 mg/dL), and the remaining 136 from DDs with a tSCr of 2.0-2.99 mg/dL (lower SCr AKI group, mean tSCr 2.4 mg/dL). These two AKI groups were compared to 996 concurrent control patients receiving DD kidneys with a tSCr < 1.0 mg/dL. Mean follow-up was 69 months. Delayed graft function (DGF) rates were 51% versus 46% versus 29% (p < 0.0001), and 5-year patient and death-censored kidney graft survival rates were 96.8% versus 83.5% versus 82.2% (p = 0.002) and 86.7% versus 77.8% versus 78.8% (p = 0.18) in the high tSCr AKI versus lower tSCr AKI versus control groups, respectively.

Conclusions: Despite a higher incidence of DGF, patients receiving kidneys from DDs with tSCr levels ≥3.0 mg/dL have acceptable medium-term outcomes compared to either AKI DDs with a lower tSCr or DDs with a tSCr < 1.0 mg/dL.

Keywords: acute kidney injury; delayed graft function; graft survival; kidney donor profile index; kidney nonutilization; terminal serum creatinine level.

MeSH terms

  • Acute Kidney Injury* / etiology
  • Adult
  • Creatinine / blood
  • Delayed Graft Function / etiology
  • Female
  • Follow-Up Studies
  • Glomerular Filtration Rate
  • Graft Rejection / etiology
  • Graft Survival*
  • Humans
  • Kidney Failure, Chronic / surgery
  • Kidney Function Tests
  • Kidney Transplantation* / adverse effects
  • Male
  • Middle Aged
  • Postoperative Complications / etiology
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Survival Rate
  • Tissue Donors* / supply & distribution

Substances

  • Creatinine